Sunday, August 3, 2025

Latest

Aurora Cannabis Files For US$300 Million At The Market Financing

Aurora Cannabis (TSX: ACB) (NYSE: ACB) last night announced that it has formally filed a prospectus supplement for a US$300 million at-the-market offering. The intention to file for the financing was originally disclosed when the company released its third quarter financial results.

Sales under the at the market financing are to be made only on US-listed exchanges, with the shares under the financing to be sold on the TSX or other Canadian markets. Distributions are to be made via arrangements with Citigroup Global and Cowen and Company, with BMO Capital Markets, ATB Capital Markets, and Canaccord Genuity also participating in the arrangement.

The financing is being conducted to provide “maximum flexibility” to the company to pursue acquisitions, despite having $525 million in cash as of May 13. The company also explicitly states that it’s, “not expected to need to access the ATM Program without an accretive use of proceeds.”

The financing arrangement is effective as of May 19, 2021.

Aurora Cannabis last traded at $8.82 on the TSX.


Information for this briefing was found via Sedar and Aurora Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

STLLR Gold: The Tower Gold PEA

AngloGold Buys Another Gold Junior! Augusta Gold Acquired For $197 Million

Another Gold Deal! Aris Mining Sells Assets To McFarlane

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

Aurora Cannabis Acquires US Based CBD Company Reliva

In its latest “cost-cutting” move, Aurora Cannabis (TSX: ACB) (NYSE: ACB) announced after today’s closing...

Wednesday, May 20, 2020, 04:35:33 PM

Cantor Releases Industry Report For Cannabis, Aphria Remains Top Pick

Recently, Cantor Fitzgerald released their monthly review of Hifyre data for the four weeks ending...

Sunday, October 4, 2020, 01:57:00 PM

Aurora Cannabis: Canaccord Cuts Price Target, Lowers 2022 Estimates

On September 27, Aurora Cannabis (TSX: ACB) reported its fiscal fourth quarter results. The companies...

Wednesday, September 29, 2021, 09:42:00 AM

Nelson Peltz Resigns As Advisor To Aurora Cannabis

Aurora Cannabis (TSX: ACB) (NYSE: ACB) has seen Nelson Peltz resign as a strategic advisor...

Monday, September 28, 2020, 08:54:46 AM

Aurora Cannabis: Analysts Raise Price Targets Following Q1 Results

Yesterday, Aurora Cannabis (TSX: ACB) (NYSE: ACB) reported their first quarter 2021 results. Aurora reported...

Tuesday, November 10, 2020, 03:21:00 PM